Patients with MACE during follow-up were older, had more frequently a history of coronary revascularization, diabetes mellitus, hypercholesterolemia, family history, suspicious patient history, recent abnormal stress test and higher hs-cTnT levels than patients without MACE (Table 1). This evidence concerns the gene TNNT2 and familial hypercholesterolemia.